Emin Kose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emin Kose has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Yuksel Altinel
Department of General Surgery, Bagcilar Training and Research Hospital, University of Health Science, Istanbul, Turkey
2 shared publications - Aamir Ali Syed
Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Center, Pakistan; Shaukat Khanum Memorial Cancer Hospital and Research Centre, 7A Block R-3, M.A.Johar Town, Lahore, Pakistan
1 shared publication Aamr Hammani
1 shared publication- Abbas Chabok
Centre for Clinical Research Västmanland, Uppsala University, 72189 Västerås, Sweden
1 shared publication - Abdourahmane Ndong
Department of Surgery, Saint-Louis Regional Hospital, Gaston Berger University, Saint-Louis, Senegal
1 shared publication - Abdul Basit Ansari
Department of Medicine and Surgery Civil Hospital Karachi Pakistan
1 shared publication
Latest Publications
- Open Access
- 16 September 2026
- Published by IntechOpen
Integration of Artificial Intelligence in Biosensors and Healthcare Applications
With advancing technology, the integration of artificial intelligence (AI) and biosensor applications in the healthcare field has gained momentum, particularly in areas such as personalized treatment, early diagnosis, and precise detection. Rapid advancements have led to the development of AI-supported biosensor systems that not only detect target molecules ultra-fast, precisely, and selectively but also offer features such as economic efficiency, portability, multianalyte detection, high stability, biocompatibility, real-time analysis capability, wide linear range, low detection limit, and AI-supported intelligent data processing. Nanomaterial-modified sensors and AI algorithm-based systems offer high accuracy and performance in the analysis of complex data. This book chapter reviews current developments and potential applications of biosensors demonstrating effective performance in healthcare applications. It also presents the potential of biosensors in point-of-care and real-time monitoring systems. Beyond the uses mentioned in the patient-side and real-time monitoring sections, the impact of biosensors on the diagnosis and treatment of cancer, cardiovascular, and neurological diseases is emphasized. The integration of machine learning (ML) and deep learning (DL) techniques into the biosensor field is expected to significantly contribute to solving problems such as the early diagnosis of cancer, neurodegenerative diseases, and infections, as well as clinically support decision systems.
- 16 September 2026
- Published by IntechOpen
Open AccessIntegration of Artificial Intelligence in Biosensors and Healthcare Applications
With advancing technology, the integration of artificial intelligence (AI) and biosensor applications in the healthcare field has gained momentum, particularly in areas such as personalized treatment, early diagnosis, and precise detection. Rapid advancements have led to the development of AI-supported biosensor systems that not only detect target molecules ultra-fast, precisely, and selectively but also offer features such as economic efficiency, portability, multianalyte detection, high stability, biocompatibility, real-time analysis capability, wide linear range, low detection limit, and AI-supported intelligent data processing. Nanomaterial-modified sensors and AI algorithm-based systems offer high accuracy and performance in the analysis of complex data. This book chapter reviews current developments and potential applications of biosensors demonstrating effective performance in healthcare applications. It also presents the potential of biosensors in point-of-care and real-time monitoring systems. Beyond the uses mentioned in the patient-side and real-time monitoring sections, the impact of biosensors on the diagnosis and treatment of cancer, cardiovascular, and neurological diseases is emphasized. The integration of machine learning (ML) and deep learning (DL) techniques into the biosensor field is expected to significantly contribute to solving problems such as the early diagnosis of cancer, neurodegenerative diseases, and infections, as well as clinically support decision systems.
- 30 June 2025
- Published by Springer Nature in Current Surgery Reports
- Vol. 13 (1) , 1-5
Robotic Hepatectomy: The Evidence
- 30 June 2025
- Published by Springer Nature in Current Surgery Reports
- Vol. 13 (1) , 1-5
Robotic Hepatectomy: The Evidence
- Open Access
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Open AccessEffects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 14 September 2021
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 6 (3) , 280-286
Risk Factors Effecting Conversion from Laparoscopic Cholecystectomy to Open Surgery
- 14 September 2021
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 6 (3) , 280-286
Risk Factors Effecting Conversion from Laparoscopic Cholecystectomy to Open Surgery
- 20 October 2020
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 34 (6) , 627-636
Systemic Amelioration via Curcumin in Rats following Splenectomy: Lipid Profile, Endothelial and Oxidative Damage
We investigated the postsurgical effects of splenectomy with additional curcumin therapy, as an antioxidant, anti-inflammatory substance among the lipid profile and histopathological changes. 32 rats were randomly divided into four groups: control group (L): laparotomy, sham group: splenectomy (S), splenectomy group treated with curcumin (SC) and splenectomy group treated with corn oil (SCO) for 28 days. The primary outcomes; total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), oxidized LDL (ox-LDL) very-low-density lipoprotein (VLDL) and lectin-type oxidized LDL receptor 1 (LOX-1), secondary outcomes: nuclear factor kappa B (NF-кB), malondialdehyde (MDA), glutathione peroxidase (GPx), superoxide dismutase (SOD) were measured. Histopathological changes were examined in vascular, intestinal and lung tissues. The analysis was performed by ANOVA. TG, LDL, ox-LDL, and LOX-1 elevated in S group while reduced by curcumin compared with L group (p < 0.05). Serum and tissue levels of NF-кB and MDA were higher in S group and lower in SC group than L group (p < 0.05). Serum and intestinal levels of SOD and GPx increased in L group while reduced by curcumin (p < 0.05). Total histopathological scores of intestinal tissues were higher in S and SCO groups compared to L and SC groups (p < 0.05). No major changes in vascular and lung tissues were observed except the lymphoid follicles which was higher in S and SCO groups compared to L and SC groups (p < 0.05). Curcumin partially improved the lipid profile dysfunction by modulating NF-кB, MDA, SOD, and GPx in splenectomized rats while less likely improving any vascular and alveolar regeneration.
- 20 October 2020
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 34 (6) , 627-636
Systemic Amelioration via Curcumin in Rats following Splenectomy: Lipid Profile, Endothelial and Oxidative Damage
We investigated the postsurgical effects of splenectomy with additional curcumin therapy, as an antioxidant, anti-inflammatory substance among the lipid profile and histopathological changes. 32 rats were randomly divided into four groups: control group (L): laparotomy, sham group: splenectomy (S), splenectomy group treated with curcumin (SC) and splenectomy group treated with corn oil (SCO) for 28 days. The primary outcomes; total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), oxidized LDL (ox-LDL) very-low-density lipoprotein (VLDL) and lectin-type oxidized LDL receptor 1 (LOX-1), secondary outcomes: nuclear factor kappa B (NF-кB), malondialdehyde (MDA), glutathione peroxidase (GPx), superoxide dismutase (SOD) were measured. Histopathological changes were examined in vascular, intestinal and lung tissues. The analysis was performed by ANOVA. TG, LDL, ox-LDL, and LOX-1 elevated in S group while reduced by curcumin compared with L group (p < 0.05). Serum and tissue levels of NF-кB and MDA were higher in S group and lower in SC group than L group (p < 0.05). Serum and intestinal levels of SOD and GPx increased in L group while reduced by curcumin (p < 0.05). Total histopathological scores of intestinal tissues were higher in S and SCO groups compared to L and SC groups (p < 0.05). No major changes in vascular and lung tissues were observed except the lymphoid follicles which was higher in S and SCO groups compared to L and SC groups (p < 0.05). Curcumin partially improved the lipid profile dysfunction by modulating NF-кB, MDA, SOD, and GPx in splenectomized rats while less likely improving any vascular and alveolar regeneration.
- Open Access
- 15 March 2019
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 9 (1) , 22-26
Effect of Duration of Calot’s Triangle Dissection on the Definition of Difficult Cholecystectomy
- 15 March 2019
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 9 (1) , 22-26
Open AccessEffect of Duration of Calot’s Triangle Dissection on the Definition of Difficult Cholecystectomy
- Open Access
- 15 March 2019
- Published by Archives of Clinical and Experimental Medicine in ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
- Vol. 4 (1) , 45-48
Retrospective analysis of risk factors for development of biliary fistula after liver cyst hydatid surgery
Aim: Hepatic hydatidosis is common parasitosis in Turkey and caused by Echinococcus granulosus. Biliary fistula is the most common complication after liver hydatid cyst surgery. The aim of this study was to investigate an appropriate treatment strategy for patients whose biliary fistula might develop, by revealing variables that affect biliary fistula.Methods: A total of 118 patients who underwent liver hydatid cyst surgery were included in this study. The following variables were analyzed between patients with biliary fistula (group 2) and without fistula (group 1): Age, gender, hematologic and liver function tests, and features of the cysts (type, cyst size, number, and localization).Results: Cystobiliary fistula was detected in 19 (16%) of 118 patients. In-group 2, cyst size, white blood cell, alkaline phosphatase and g-Glutamyl transpeptidase levels were higher than group 1 on univariate analysis (p=0.03, p=0.008, p=0.04 and p=0.001, respectively). In the multivariate model, only cyst diameter remained as an independent predictor (odds ratio 0.03, 95% confidence interval 0.002 to 0.06; p=0.03) On the receiver operating characteristic curve, the 100% sensitive, 100% specific, and optimal cutoffs of the cyst diameter were 7.5 cm, 4.0 cm and14.6 cm, respectively (The area under the receiver operator characteristic curve was 0.67). Conclusion: Preoperative cyst size is a valuable parameter for predicting biliary fistula. Our study suggests that cyst size greater than 7.5 cm is a risk factor for biliary fistula.
- 15 March 2019
- Published by Archives of Clinical and Experimental Medicine in ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
- Vol. 4 (1) , 45-48
Open AccessRetrospective analysis of risk factors for development of biliary fistula after liver cyst hydatid surgery
Aim: Hepatic hydatidosis is common parasitosis in Turkey and caused by Echinococcus granulosus. Biliary fistula is the most common complication after liver hydatid cyst surgery. The aim of this study was to investigate an appropriate treatment strategy for patients whose biliary fistula might develop, by revealing variables that affect biliary fistula.Methods: A total of 118 patients who underwent liver hydatid cyst surgery were included in this study. The following variables were analyzed between patients with biliary fistula (group 2) and without fistula (group 1): Age, gender, hematologic and liver function tests, and features of the cysts (type, cyst size, number, and localization).Results: Cystobiliary fistula was detected in 19 (16%) of 118 patients. In-group 2, cyst size, white blood cell, alkaline phosphatase and g-Glutamyl transpeptidase levels were higher than group 1 on univariate analysis (p=0.03, p=0.008, p=0.04 and p=0.001, respectively). In the multivariate model, only cyst diameter remained as an independent predictor (odds ratio 0.03, 95% confidence interval 0.002 to 0.06; p=0.03) On the receiver operating characteristic curve, the 100% sensitive, 100% specific, and optimal cutoffs of the cyst diameter were 7.5 cm, 4.0 cm and14.6 cm, respectively (The area under the receiver operator characteristic curve was 0.67). Conclusion: Preoperative cyst size is a valuable parameter for predicting biliary fistula. Our study suggests that cyst size greater than 7.5 cm is a risk factor for biliary fistula.